Billionaire Johann Rupert officially takes control of 50 private hospitals in South Africa
Johann Rupert’s Remgro has officially taken full control of Mediclinic Holdings’ Southern African business, giving the billionaire’s company ownership of around 50 private hospitals across South Africa and Namibia.
The transaction follows approval by the Competition Tribunal at the beginning of June 2026 and marks the completion of an agreement first announced in December 2025.
The deal saw Remgro and Luxembourg-based Investment Holding Limited (IHL), a subsidiary of MSC Mediterranean Shipping Company, divide their jointly owned interests in Mediclinic Holdings.
Before the transaction, Remgro and IHL each held a 50% stake in Mediclinic Holdings, which owns the Swiss-based Hirslanden Group and the South African-based Mediclinic International Group.
Following the completion of the deal, Remgro now owns 100% of Mediclinic International, while IHL has become the sole owner of Switzerland’s Hirslanden Group.
Mediclinic International is one of Southern Africa’s largest private healthcare providers.
It operates around 50 hospitals, 15 day clinics, six sub-acute facilities and six mental health facilities across South Africa, as well as three private hospitals in Namibia. The group has more than 8,991 beds.
Remgro’s acquisition also includes Mediclinic International’s subsidiaries, such as the Intercare group of companies and emergency medical services provider ER24.
When the transaction was announced, both sides agreed to a baseline purchase price of $950 million (around R15.7 billion) for their respective acquisitions
However, adjustments resulting from leakages and accruals between the announcement and the transaction’s completion changed the final amounts paid.
As a result, Remgro paid $947 million (around R15.6 billion) for Mediclinic International, while IHL paid $1.08 billion (around R17.7 billion) for Hirslanden.
With all conditions met and the transactions completed, Remgro has now officially assumed full ownership of Mediclinic’s Southern African operations.
The Competition Tribunal approved the merger, subject to employment-related conditions intended to protect workers.
Following a recommendation by the Competition Commission, the Tribunal required that the merger parties not retrench any permanent or fixed-term contract employees as a result of the transaction during the agreed moratorium period.
Better positioned
Remgro previously said the restructuring reflects significant changes taking place in the global healthcare industry.
According to the company, healthcare providers are facing growing expectations around the quality and breadth of services they offer, while simultaneously dealing with increasing pricing and regulatory pressures.
Remgro and IHL concluded that each company would be better positioned by taking full ownership of the healthcare businesses operating in their respective home markets.
“This will also better position both businesses to unlock value through their strengthened local partnerships and brand presence,” Remgro said when it announced the transaction.
The company added that the new ownership structure would allow each business to tailor its strategy more effectively to local market conditions while pursuing long-term growth opportunities.
“Remgro and IHL remain strongly aligned in their common desire to invest for the long term in the private healthcare sector broadly,” the investment company said.
Loading ...